News Daily News NCDR Analyses Offer Insights Into First-Generation Watchman Outcomes L.A. McKeown May 03, 2022
News Daily News Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality Michael O'Riordan March 10, 2022
News Daily News Antithrombotics Not Worth the Risk During Endovascular Stroke Therapy Todd Neale March 07, 2022
News Daily News Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis Yael L. Maxwell March 01, 2022
News Daily News Fewer Diabetic Complications Seen When NOACs Given for AF L.A. McKeown February 22, 2022
News Conference News ISC 2022 Tenecteplase Feasible Up to 24 Hours After Stroke Todd Neale February 15, 2022
News Conference News ISC 2022 ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis Todd Neale February 10, 2022
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Daily News PASCAL Pinpoints Patients With Strokes Causally Related to PFO Yael L. Maxwell December 20, 2021
News Daily News No Uptick in CVD Events After COVID-19 Vaccination in Older Adults Michael O'Riordan November 29, 2021
News Daily News Rivaroxaban Again Linked to More Bleeding vs Other DOACs Caitlin E. Cox October 11, 2021
News Daily News Long-term Anticoagulation After Unprovoked VTE: New Insights Shelley Wood September 13, 2021
News Daily News Switching to Tenecteplase for Stroke Thrombolysis May Boost Outcomes Todd Neale September 09, 2021
News Conference News ESC 2021 Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD Michael O'Riordan August 29, 2021
News Conference News HRS 2021 RF-Based Energy Closes Residual Leaks After Watchman Implantation Michael O'Riordan August 09, 2021